
Preclinical rheumatoid arthritis and rheumatoid arthritis prevention
Author(s) -
H. Karl Greenblatt,
HyounAh Kim,
Leah F. Bettner,
Kevin D. Deane
Publication year - 2020
Publication title -
current opinion in rheumatology/current opinion in rheumatology, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.452
H-Index - 112
eISSN - 1080-8175
pISSN - 1040-8711
DOI - 10.1097/bor.0000000000000708
Subject(s) - medicine , rheumatoid arthritis , rituximab , autoantibody , abatacept , hydroxychloroquine , immunology , rheumatoid factor , arthritis , synovitis , autoimmunity , disease , autoimmune disease , antibody , covid-19 , infectious disease (medical specialty)
This review is to provide an update on the current understanding of rheumatoid arthritis (RA) development related to disease development prior to the onset clinically apparent synovitis (i.e. Pre-RA), and opportunities for disease prevention.